Ambryon Biosciences

Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases

Tóth et al. (2020). Nucleic Acids ResResearch

Cas12a genome editing was constrained by its rare TTTV PAM; this paper combined the RR and RVR PAM-altering mutations into LbCas12a-RVRR, then added D156R to create impLbCas12a. LbCas12a-RVRR tolerates 15 of 16 possible TNTN PAM sequences.

Key findings

  • impLbCas12a does not exceed enAsCas12a on NTTV-PAM targets but exceeds it on RR- and RVR-related PAMs; their overlapping but distinct PAM preferences give a combined target space larger than either nuclease alone.

  • The canonical TTTV PAM occurs at a theoretical frequency of 3/256 versus 16/256 for SpCas9's NGG; AsCas12a-RVR and -RR raise it to 6/256 and 9/256, and LbCas12a-RVRR to roughly three-fold that of the RR variant.

  • LbCas12a-RR is robust on TCTN, but LbCas12a-RVRR is only moderate on TCTV and negligible on TCTT; RVRR newly gains activity on TGTN, highest with A or C at position -1 (TGTA, TGTC).

  • LbCas12a-RVRR is active on 15 of 16 TNTN PAMs, the exception being TCTT, with residual preference for a -3 thymine, and shows robust activity on the TACC, TTCC and CTCC PAMs associated with the RVR and RR parents.

  • GUIDE-seq at seven TTTV targets: LbCas12a-RVRR cleaves more off-target sites than WT at six (not FANCF target 1), including sites with PAMs differing at all three thymidines; within WT's off-target set, its off-target-to-on-target ratio rises only slightly.

  • Swapping dLbCas12a-WT for dLbCas12a-RVRR in dCpf1 cytidine base editor gives similar C-to-T editing at TTTV targets and higher editing at TNTN targets than dLbCas12a-WT-BE; across 21 off-target sites with up to four mismatches, off-target editing does not increase.

  • D156R, the LbCas12a analogue of AsCas12a E174R, added to LbCas12a-RVRR gives impLbCas12a (D156R, G532R, K538V, Y542R, K595R) and may raise average activity approximately 1.3-fold, most on TACV (1.9-fold) and TATV (1.7-fold), less than E174R's gain on AsCas12a at TTTV PAMs.

Author abstract

The widespread use of Cas12a (formerly Cpf1) nucleases for genome engineering is limited by their requirement for a rather long TTTV protospacer adjacent motif (PAM) sequence. Here we have aimed to loosen these PAM constraints and have generated new PAM mutant variants of the four Cas12a orthologs that are active in mammalian and plant cells, by combining the mutations of their corresponding RR and RVR variants with altered PAM specificities. LbCas12a-RVRR showing the highest activity was selected for an in-depth characterization of its PAM preferences in mammalian cells, using a plasmid-based assay. The consensus PAM sequence of LbCas12a-RVRR resembles a TNTN motif, but also includes TACV, TTCV CTCV and CCCV. The D156R mutation in improved LbCas12a (impLbCas12a) was found to further increase the activity of that variant in a PAM-dependent manner. Due to the overlapping but still different PAM preferences of impLbCas12a and the recently reported enAsCas12a variant, they complement each other to provide increased efficiency for genome editing and transcriptome modulating applications.

Identifiers & revision